The following is true of clopidogrel except:
A. It is a GPIIb/IIIa receptor antagonist
B. It inhibits fibrinogen induced platelet
aggregation
C. It is indicated for prevention of stroke in
patients with transient ischaemic attacks
D. It is a prodrug
A. It is a GPIIb/IIIa receptor antagonist
B. It inhibits fibrinogen induced platelet
aggregation
C. It is indicated for prevention of stroke in
patients with transient ischaemic attacks
D. It is a prodrug